Financial Events

Scandion Oncology’s Executive Management will host a webcast and conference call at 10:00 CET

Scandion Oncology’s Executive Management will host a webcast and conference call presenting the upcoming Rights Issue.

Meet Scandion Oncology at Redeye Transactions

Scandion Oncology (Scandion) will publish its Q2 2022 interim report on Thursday, August 25, 2022 before 09:00 CET. Scandion’s Executive Management will host a webcast and conference call the same day at 10:00 CET presenting the results and a company update. At the end of the presentation there will be a Q&A session. Access to the event can be obtained as follows: LIVE access on Thursday August 25, 2022 at 10:00 CET https://financialhearings.com/event/43548  

Scandion Oncology will publish its Q3 2022 interim report on Wednesday November 16, 2022, before 09:00 CET. Scandion’s Executive Management will host a webcast and conference call the same day at 10:00 CET presenting the results and a company update. At the end of the presentation there will be a Q&A session. Access to the event can be obtained as follows: LIVE access on Wednesday November 16, 2022, at 10:00 CET Webcast: https://financialhearings.com/event/45864 Dial-in: DK: +4578150110 SE: +46850558354 UK: +443333009266 US: +1 6319131422 PIN US: 42830998# REPLAY access Webcast replay will be available at http://www.scandiononcology.com in the Investors section and at http://www.financialhearings.com For further information please contact: Johnny Stilou, Acting CEO & CFO Phone: +45 2960 3532 E-mail: jos@scandiononcology.com

Webcast for this event can be found here

Webcast link